CH446366A - Verfahren zur Herstellung von 3-(5-Nitro-2-furyl)-4H-1,2,4-triazolen - Google Patents

Verfahren zur Herstellung von 3-(5-Nitro-2-furyl)-4H-1,2,4-triazolen

Info

Publication number
CH446366A
CH446366A CH1615064A CH1615064A CH446366A CH 446366 A CH446366 A CH 446366A CH 1615064 A CH1615064 A CH 1615064A CH 1615064 A CH1615064 A CH 1615064A CH 446366 A CH446366 A CH 446366A
Authority
CH
Switzerland
Prior art keywords
triazoles
furyl
nitro
preparation
Prior art date
Application number
CH1615064A
Other languages
English (en)
Inventor
Albert Burch Homer
Original Assignee
Norwich Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharma Co filed Critical Norwich Pharma Co
Publication of CH446366A publication Critical patent/CH446366A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70Nitro radicals
    • C07D307/71Nitro radicals attached in position 5
    • C07D307/72Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • C07D307/74Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by hydrazino or hydrazono or such substituted radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Fuel Combustion (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
CH1615064A 1964-01-09 1964-12-15 Verfahren zur Herstellung von 3-(5-Nitro-2-furyl)-4H-1,2,4-triazolen CH446366A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33664364A 1964-01-09 1964-01-09
US438743A US3277110A (en) 1964-01-09 1965-03-10 Certain 5-nitro-2-furyl-1, 2, 4-triazoles

Publications (1)

Publication Number Publication Date
CH446366A true CH446366A (de) 1967-11-15

Family

ID=26990308

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1615064A CH446366A (de) 1964-01-09 1964-12-15 Verfahren zur Herstellung von 3-(5-Nitro-2-furyl)-4H-1,2,4-triazolen
CH333366A CH475277A (de) 1964-01-09 1966-03-09 Verfahren zur Herstellung von 5-Nitro-2-furyl-1,2,4-triazolen

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH333366A CH475277A (de) 1964-01-09 1966-03-09 Verfahren zur Herstellung von 5-Nitro-2-furyl-1,2,4-triazolen

Country Status (12)

Country Link
US (1) US3277110A (de)
BE (1) BE676459A (de)
BR (2) BR6566096D0 (de)
CH (2) CH446366A (de)
DE (2) DE1221231B (de)
DK (1) DK119771B (de)
FR (1) FR163F (de)
GB (2) GB1089012A (de)
IL (1) IL22395A (de)
NL (2) NL6500123A (de)
NO (2) NO116416B (de)
SE (1) SE303502B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3427387A (en) * 1964-01-09 1969-02-11 Norwich Pharma Co Antibacterial composition containing 5-nitro-2-furyl-1,2,4-triazoles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE541700C (de) * 1928-04-08 1932-01-15 C H Boehringer Sohn Akt Ges Verfahren zur Darstellung von 1,2,4-Triazolen
DE543026C (de) * 1928-07-28 1932-02-01 C H Boehringer Sohn Akt Ges Verfahren zur Darstellung von Triazolen
US2723274A (en) * 1954-03-08 1955-11-08 American Cyanamid Co Ureidotriazoles
US2959518A (en) * 1956-06-11 1960-11-08 Philips Corp Fungicides
US2893343A (en) * 1956-11-29 1959-07-07 Charles R Judd Pneumatic tire accessories
US2898343A (en) * 1957-11-18 1959-08-04 American Cyanamid Co Anthraquinone triazoles
US2953491A (en) * 1957-11-21 1960-09-20 American Cyanamid Co Fungicide
FR1320380A (fr) * 1961-04-14 1963-03-08 Boehringer & Soehne Gmbh Procédé de préparation de nouveaux dérivés du 5-nitrofurane

Also Published As

Publication number Publication date
FR163F (de) 1967-05-22
CH475277A (de) 1969-07-15
BE676459A (de) 1966-08-16
DK119771B (da) 1971-02-22
SE303502B (de) 1968-09-02
BR6566096D0 (pt) 1973-08-02
IL22395A (en) 1968-04-25
US3277110A (en) 1966-10-04
DE1620081A1 (de) 1970-03-12
NL6500123A (de) 1965-07-12
NO116416B (de) 1969-03-24
GB1089012A (en) 1967-11-01
DE1221231B (de) 1966-07-21
BR6677749D0 (pt) 1973-09-11
NO116417B (de) 1969-03-24
GB1100413A (en) 1968-01-24
NL6602208A (de) 1966-09-12

Similar Documents

Publication Publication Date Title
CH460027A (de) Verfahren zur Herstellung von Spiro-steroid-6,3'-1-pyrazolinen
CH471803A (de) Verfahren zur Herstellung von 2,4,6,8,9-Pentaaza-bizyclo-(3.3.1)-nonna-2,6-dienen
AT289785B (de) Verfahren zur Herstellung von 1,5-disubstituierten 4-Cyanopyrazolen
CH485775A (de) Verfahren zur Herstellung von 9-B-D-Ribofuranosyl-7-deazapurin-3',5'-cyclophosphaten
CH468998A (de) Verfahren zur Herstellung von 2,3-Dihydro-2,2-dimethyl-7-benzofuranyl-N-methylcarbamat
CH451103A (de) Verfahren zur Herstellung von 1,4-Dichlortetrafluorbenzol
AT257570B (de) Verfahren zur Herstellung von 1,2,4-Trimethyl-5-isopropylbenzol
CH438340A (de) Verfahren zur Herstellung von Tetrahydro-1,3,5-thiadiazin-2-thionen
CH476000A (de) Verfahren zur Herstellung von 2-Carbodiimino-1,3,5-Triazinen
CH446366A (de) Verfahren zur Herstellung von 3-(5-Nitro-2-furyl)-4H-1,2,4-triazolen
AT257596B (de) Verfahren zur Herstellung von neuen 1,2,4-Triazolderivaten
CH442329A (de) Verfahren zur Herstellung von Tetrahydro-1,3,5-thiadiazin-2-thionen
CH460743A (de) Verfahren zur Herstellung von 3',4',5'-Trimethoxy-3-aminoacrylophenonen
CH451171A (de) Verfahren zur Herstellung von 1,3,4-Oxdiazolen
CH472420A (de) Verfahren zur Herstellung von 3,5-disubstituierten Isoxazol-Derivaten
AT254859B (de) Verfahren zur Herstellung von neuen Derivaten des 3-(γ-Amino-β-hydroxypropyl)-4-alkyl-7-hydroxy-cumarins
AT297702B (de) Verfahren zur Herstellung des neuen 3-(Tetrahydropyranyl-2')-1,2,3,4,6,7-hexahydro-5H-cyclopentapyrimidin-2,4-dions
CH498133A (de) Verfahren zur Herstellung von 1,2,4-Oxadiazolidin-3,5-dionen
DD70886A1 (de) verfahren zur Herstellung von 3-[4-Nitroimidazolyt-(5)]-1,2,4,-oxadiazolen
AT260205B (de) Verfahren zur Herstellung von 2,2,6,6-Tetrachlorcylochexanon
CH467244A (de) Verfahren zur Herstellung von L-a-Methyl-(3,4-disubstituierten-phenyl)-alaninen
CH482638A (de) Verfahren zur Herstellung von 1,3-Dicarbonylverbindungen
CH467287A (de) Verfahren zur Herstellung von 5-Imino-1-methylcarbamoyl-3-(5-nitro-2-furyl)- 2-1,2,4-triazolin
AT250384B (de) Verfahren zur Herstellung von 5-(3, 4-Dihydroxybenzyl)-5-methylhydantion
CH441348A (de) Verfahren zur Herstellung von 3-(5-Nitro-2-furyl)- 2-1,2,4-triazolinen